Beyond the Brain: The Texas Neurological Society Podcast

Alzheimer’s treatment is changing fast. Dr. Eddie Patton and Dr. Khushboo Verma explore anti-amyloid therapies, biomarker testing, safety monitoring, access challenges, caregiver education, and the lifestyle strategies helping patients take a more active role in brain health.

Learn more about The Texas Neurological Society: https://www.texasneurologist.org/

Learn more about Dr. Verma: https://www.uttyler.edu/directory/neurology-residency/khushboo-verma.php

Watch Dr. Verma's YouTube channel: https://youtube.com/@thedementiadoctor?si=EDksOKUfduzl6Pcy

Key Takeaways

1. Anti-amyloid therapies have created new treatment options for eligible people with early Alzheimer’s disease and have accelerated the use of biomarker testing.

2. Mild cognitive impairment can involve subtle cognitive changes that make people more error-prone while they remain largely independent in daily life.

3. Alzheimer’s biomarkers may include amyloid PET scans, cerebrospinal fluid testing through lumbar puncture, and blood-based tests that help identify who needs confirmatory testing.

4. Access remains a major challenge because there are relatively few dementia specialists and treatment requires careful selection, monitoring, and follow-up.

5. ARIA, or amyloid-related imaging abnormalities, can involve swelling or bleeding in the brain, which is why MRI safety monitoring is essential during treatment.

6. The clinical benefit of current anti-amyloid therapies remains an evolving area of research, and treatment decisions should involve clear conversations about potential benefits and risks.

7. Lifestyle measures—including exercise, sleep, nutrition, social connection, and mood management—can support cognitive health and give patients meaningful actions they can take.

8. Education through video and social media can help families get reliable information while they wait to see a dementia specialist.

See omnystudio.com/listener for privacy information.

From Alzheimer’s and ALS to stroke disparities, MS, Parkinson’s, neurotoxicity, and palliative care, this conference recap captures the ideas shaping neurology in Texas. Hear key lessons from TNS Summer 2026 speakers, attendees, and experts working to improve care across the state.

Learn more about The Texas Neurological Society: https://www.texasneurologist.org/

Key Takeaways

1. Multiple sclerosis care is becoming more individualized through updated diagnostic criteria, biomarkers, and treatment selection based on each patient’s disease activity.

2. Early-onset Parkinson’s disease requires special attention to stigma, delayed diagnosis, employment, family responsibilities, and long-term quality of life.

3. New cancer therapies can cause complex neurological complications, making education and early recognition increasingly important for neurologists.

4. ALS research is expanding rapidly, offering growing hope through clinical trials, biomarkers, collaborative research networks, and a focus on personalized treatment.

5. Alzheimer’s disease care is evolving with disease-modifying therapies, biomarker testing, and new approaches to mild cognitive impairment.

6. Stroke care must address disparities in prevention, treatment access, geography, language, and social conditions.

7. Palliative care plays a vital role in helping patients and families navigate difficult decisions in neurodegenerative disease.

Timestamped Overview

00:00 Start of episode and introduction from the TNS Summer 2026 Conference in San Antonio

00:04 TNS Executive Director Ky Camero joins Dr. Eddie Patton to discuss conference highlights

00:30 Dr. Patton reflects on Dr. Ethan Meltzer’s presentation on multiple sclerosis diagnosis and treatment

01:15 Updated MS diagnostic criteria, disease mimics, biomarkers, and individualized treatment decisions

02:15 Introduction to early-onset Parkinson’s disease with Dr. Erin Furr-Stimming and Dr. Raja Mehanna

02:45 Defining early-onset Parkinson’s disease and why terminology matters

03:35 Why Parkinson’s disease can be diagnosed later in younger adults

04:35 The unique impact of Parkinson’s diagnosis on careers, young families, and long-term planning

05:40 Counseling patients with early-onset Parkinson’s disease about employment, stigma, and support

06:50 Hope for the future: research into disease-modifying therapies and the importance of avoiding unproven treatment claims

08:10 Discussion of neurological toxicities from cancer therapies with a UTHealth Houston neurology resident

08:45 CAR-T therapy, bispecific antibodies, and emerging neurological complications of cancer treatment

09:40 Recognizing and treating complications such as myasthenia gravis in patients receiving cancer therapies

10:55 Dr. Leorah Freeman reflects on the evolving treatment landscape for ALS

11:25 From hopelessness to possibility: how new research may help people live longer and better with ALS

12:15 The importance of clinical trial networks, biomarkers, and collaborative research infrastructure in ALS

13:35 Dr. Patton recaps the conference’s session on joy, purpose, and burnout prevention in neurology

14:05 Review of early-onset Parkinson’s disease, MS diagnosis and treatment, and Alzheimer’s disease-modifying therapies

16:15 ALS research advances and the role of palliative care in neurodegenerative disease

17:10 Closing reflections on the TNS Summer 2026 Conference and invitation to attend the upcoming TNS Winter Conference

See omnystudio.com/listener for privacy information.

Burnout is more than stress. It can change how neurologists experience their work and connect with patients. Dr. Eddie Patton talks with Dr. Carrie Hersh about recognizing burnout, seeking support, protecting purpose, and creating healthcare systems where clinicians can thrive.

Learn more about The Texas Neurological Society: https://www.texasneurologist.org/

Key Takeaways

1. Burnout involves emotional exhaustion, depersonalization or disengagement, and a reduced sense of personal accomplishment.

2. Dr. Hersh shares her personal experience with burnout and the importance of taking time away, reflecting, and asking for help.

3. Burnout can affect patient care when clinicians feel detached, rushed, or unable to be fully present during visits.

4. Neurologists face distinctive pressures because they care for patients with complex, chronic conditions while navigating administrative burdens, prior authorizations, and limited support.

5. Early warning signs can include persistent exhaustion, cynicism, disengagement, feeling ineffective, and feedback from colleagues or patients that something seems different.

Timestamped Overview

00:03 Dr. Eddie Patton introduces the topic: burnout in neurology

00:35 Dr. Patton shares concerning workforce statistics and introduces Dr. Carrie Hersh, neurologist, MS specialist, neuroimmunologist, and president of the Consortium of MS Centers

01:50 What burnout is—and how it differs from everyday stress and depression

02:07 The three core dimensions of burnout: emotional exhaustion, depersonalization, and loss of personal accomplishment

05:52 The importance of a supportive medical director, taking medical leave, and beginning the work of recovery

07:47 Why leadership support and psychological safety can make a life-changing difference

08:05 Dr. Patton reflects on recognizing when he was not fully present with a patient

09:50 Dr. Hersh reflects on recognizing that burnout had been building for months before her breaking point

12:10 Why burnout is a systems-level problem—not simply an individual issue

14:23 AI-assisted documentation and its potential to reduce charting burden and improve presence during patient visits

16:28 How technology can help make care less transactional and create more meaningful conversations

17:55 Why patients value feeling heard, seen, and genuinely cared for

19:11 Subtle warning signs: physical exhaustion, stress, withdrawal, disengagement, cynicism, and feeling that your work no longer matters

22:02 Practical strategies to prevent or address burnout

24:02 The organizational responsibility to address burnout and support the neurology workforce

26:00 A caution about AI: technology should support meaning, joy, and patient connection—not just efficiency

27:57 Dr. Hersh’s closing message: clinicians can provide excellent care without losing their humanity

28:33 Closing remarks and invitation to tune in for future episodes

See omnystudio.com/listener for privacy information.

Welcome to episode three of Beyond the Brain: The Texas Neurological Society Podcast.

Texas has just approved a groundbreaking three-billion-dollar investment in dementia and neurodegenerative disease research, but that funding is temporarily tied up in court. In this solo episode, host Dr. Eddie Patton explains what the Dementia Prevention and Research Institute of Texas (DPRIT) is, how it came to be, and why it could transform brain health research, care, and innovation for Texans over the next decade.

Learn more about The Texas Neurological Society: https://www.texasneurologist.org/

Key Takeaways

1. Dementia and related neurodegenerative disorders such as Alzheimer’s, Parkinson’s, Lewy body dementia, and frontotemporal dementia affect hundreds of thousands of Texans and place a heavy burden on families and caregivers.

2. DPRIT was created as a voter-approved, three-billion-dollar, ten-year initiative (approximately 300 million dollars per year) to accelerate prevention, treatment, and potential cures for dementia and other neurodegenerative diseases.

3. The program is designed not only to fund basic science but also to support early-stage, innovative neuroscience research, translational work, and commercialization that strengthens Texas’s neuroscience ecosystem.

4. DPRIT builds on the successful model of the Cancer Prevention and Research Institute of Texas (CPRIT), signaling a broad public and legislative commitment to brain health similar to Texas’s investment in cancer research.

5. Although the proposition passed with strong voter support, a pending lawsuit over voting machine testing has delayed implementation of DPRIT, leaving the institute in a legal holding pattern before funds can be distributed to researchers and institutions.

Timestamped Overview

00:13 Dr. Eddie Patton introduces DPRIT and frames it as a major dementia research initiative in Texas
01:00 Scope of dementia and neurodegenerative disease in the U.S. and Texas, including Alzheimer’s, Parkinson’s, Lewy body dementia, and frontotemporal dementia
02:18 Texas’s strong research and academic ecosystem and the need for more resources to advance Alzheimer’s and neurodegenerative disorder care
03:20 Brief history of Alzheimer’s treatments and the recent impact of anti‑amyloid therapies in shifting attention and investment
04:49 Legislative story of DPRIT: Proposition 14 goes to Texas voters and becomes the largest state‑funded dementia research program after strong approval
06:30 What DPRIT is designed to do: fund prevention, treatment, innovation, and research for dementia and related neurodegenerative disorders
07:30 How DPRIT supports early‑stage neuroscience, translational research, and commercialization while strengthening the Texas neuroscience ecosystem
09:27 Overview of the three‑billion‑dollar, ten‑year funding structure (about three hundred million dollars per year) and how it complements federal research efforts
11:42 Economic and caregiver burden of dementia in Texas and the rationale for major state investment
13:28 What DPRIT could mean for neurologists and researchers: new grants, studies, and collaborative opportunities beyond federal funding
14:54 Potential impact on the entire research pipeline, from basic science to clinical trials and improved models of care
16:15 Current status of DPRIT funding and explanation of lawsuits challenging voting machine testing that have delayed implementation
17:57 Looking ahead: resolving legal challenges, building oversight and review structures, and responsibly deploying the three‑billion‑dollar fund
18:30 Closing remarks from Dr. Patton, emphasizing DPRIT as a major step forward in Texas’s commitment to brain health and inviting listeners to future updates on DPRIT and other neurology advocacy issues

See omnystudio.com/listener for privacy information.

Welcome to episode two of Beyond the Brain: The Texas Neurological Society Podcast.

Every minute after a stroke, two million brain cells die — and mobile stroke units are racing to close that gap. Stroke pioneer Dr. James Grotta joins host Dr. Eddie Patton to break down how these "emergency rooms on wheels" are transforming acute stroke care in Texas and beyond, from the science of clot-busting drugs to the legislative battles required to fund and sustain them.

Learn more about The Texas Neurological Society: texasneurologist.org

Key Takeaways

1. Mobile stroke units function as emergency rooms on wheels, arriving on scene with a CT scanner and clot-busting medications, cutting treatment time by 30–45 minutes compared to traditional ambulance transport.

2. Time is the critical factor in stroke treatment. Patients treated within the first hour with TPA or TNK have a 70–80% chance of full recovery, compared to only ~30% if treated 3–4.5 hours later.

3. Recognizing stroke symptoms fast matters: use the F.A.S.T. acronym — Face drooping, Arm drift, Speech slurred, Time to call 911.

4. Texas secured a $5 million state fund in the most recent legislative session to expand mobile stroke units, with Houston, El Paso, and Austin set to receive new units. Geo-mapping research suggests just 14–30 strategically placed units could cover the entire state.

5. The biggest barrier to expansion is reimbursement. Medicare currently has no billing pathway for mobile stroke units. Texas took a first step by allowing units to bill as part of a hospital system, the model that federal policy must now follow.

Timestamped Overview

00:00 Start of episode
00:31 Dr. Eddie Patton introduces the topic: Mobile Stroke Units
02:35 Introduction of Dr. James Grotta, stroke pioneer and founder of the nation's first mobile stroke unit at Memorial Hermann
03:00 What is a mobile stroke unit and how does it differ from a standard EMS response?
05:21 Two million brain cells die per minute 
05:58 How clot-busting drugs TPA and TNK work and their time-sensitive effectiveness
08:24 Real patient stories illustrating delays that cost treatment windows
10:08 The F.A.S.T. acronym and recognizing stroke symptoms
12:39 Legislative victories: Texas's $5 million mobile stroke unit fund
13:26 The cost structure of mobile stroke units and the reimbursement gap
16:51 Plans for new units in Houston, El Paso, and Austin
17:50 Geospatial analysis: 14–30 units could cover all of Texas
19:46 The "rendezvous" model for serving rural Texas
23:06 New Texas legislation creating a hospital-system billing pathway for mobile stroke units
25:47 American Heart Association's new Level 1A recommendation for mobile stroke units
27:04 Dr. Grotta's call to action for policymakers and hospital administrators
28:34 Closing remarks and encouragement to neurologists to advocate for expanded funding

See omnystudio.com/listener for privacy information.

Welcome to episode one of Beyond the Brain: The Texas Neurology Society Podcast.

Neurologist and TNS Board Member Dr. Ethan Meltzer joins host Dr. Eddie Patton to discuss his advocacy work in Washington and Austin, including telehealth, Medicare reimbursement, and research funding. This inaugural episode highlights how neurologists can influence policy and improve access to care for patients across Texas and beyond.

Learn more about The Texas Neurological Society: https://www.texasneurologist.org/

Key takeaways

1. Neurologists can achieve meaningful change quickly at the state level, with TNS already helping pass 10 neurology‑related bills in one Texas legislative session. Local events like TNS Advocacy Day in Austin let neurologists connect directly with representatives on issues affecting Texans.

2. Work on federal policy, such as fixing Medicare reimbursement and extending telehealth flexibilities, often takes years of consistent pressure. Long‑term engagement with Congress and staff helps build relationships that eventually lead to breakthroughs in healthcare policy.

3. When advocating on the Hill, concrete patient experiences—like a disabled patient traveling hours to clinic—make abstract policy issues tangible. These stories help lawmakers see how telehealth, prior authorizations, and reimbursement changes directly affect their constituents.

4. The Connect for Health Act aims to make telehealth flexibilities permanent in the post‑COVID era, which is critical for Texans living in rural or underserved areas. Broad bipartisan support in both the House and Senate reflects how widely this benefit is understood.

5. Flat Medicare reimbursement and shrinking practice revenue threaten neurologist retention and practice viability, especially in a specialty with already long wait times. Meanwhile, sustained federal research funding—such as for the BRAIN Initiative—is key to developing new treatments for diseases like Alzheimer’s, Parkinson’s, and ALS.

Timestamped overview

00:00 Start of episode
00:13 Dr. Eddie Patton introduces himself and the topic: Advocacy in Action
00:53 Introduction of Dr. Ethan Meltzer, TNS board member and advocate
02:19 Background on Dr. Meltzer’s work and advocacy roles
03:27 How he entered advocacy after residency and Neurology on the Hill 2019
04:41 Discussion of state‑level advocacy in Texas, including Deeper funding for dementia
06:23 Comparing federal vs. state advocacy speeds and opportunities
07:50 Importance of sharing patient‑level impact when talking to lawmakers
08:42 Telehealth stories and the impact of flexibilities lapsing
10:38 Shift to telehealth as a core advocacy ask
11:41 Connect for Health Act and bipartisan co‑sponsor numbers
13:17 Successes from the visit, including new co‑sponsors in Texas
14:10 Shift to physician reimbursement and Medicare “flatline”
15:11 Reimbursement impact on trainee interest and practice sustainability
18:05 How physician pay affects practice consolidation and access
19:56 Link between federal advocacy and Medicare‑driven reimbursement
21:26 Research funding and the BRAIN Initiative
23:46 Ask on BRAIN Initiative funding ramp‑down and economic impact
24:51 Examples of how research turns into better treatments for MS and other diseases
26:08 Ethan’s personal highlights from Neurology on the Hill
27:39 Closing remarks and call to keep advocating for neurology and patients

See omnystudio.com/listener for privacy information.

Every neurologist has stories that stay with them. Stories about patients. Families. Tough calls in the middle of the night.

Beyond the Brain: The Texas Neurological Society Podcast, is where those stories meet the science, the systems, and the people driving change. In this podcast, you’ll hear from clinicians, researchers, and innovators about what is working in neurology today and what still needs to change.

From stroke care in the field to complex autoimmune disease, from practice management to physician wellness, each episode delivers clear, useful insight you can bring back to your team. Some conversations are intimate and personal. Others zoom out to the statewide view. All of them aim at better care for people with neurologic disease across Texas.

Follow Beyond the Brain on your favorite listening app, and join us as we keep pushing neurology forward, one conversation at a time.

Learn more about The Texas Neurological Society: 

https://www.texasneurologist.org/

See omnystudio.com/listener for privacy information.